Portfolio Archive - Page 58 of 60 - Bryan, Garnier & Co

1855 tombstone

Bryan Garnier & Co leads €15 million IPO of the first internet up-market wines retailer on Alternext, Euronext’s alternative investment market

Innate Pharma 2006 tombstone

Bryan, Garnier & Co successfully leads a €33.7 million IPO for Innate Pharma

Risc Group 2006 tombstone

Bryan Garnier & Co successfully leads a EUR 19.1 million follow-on offering for Risc Group (Euronext: RSC)

Access Commerce tombstone

Bryan Garnier & Co successfully leads a EUR 3.8 million follow-on offering for Access Commerce (Euronext: CES), the leading Multi-channel Commerce solutions company

Divalto tombstone

Bryan, Garnier & Co successfully advised Divalto on the opening of its capital to Before, through an owner buy-out (OBO)

MEDICREA tombstone

Bryan, Garnier & Co leads a 11,5 million IPO for MEDICREA on Alternext

BioAlliance Pharma 2005 tombstone

Bryan, Garnier & Co & ING announce the successful completion of BioAlliance Pharma (Eurolist Paris : FR0010095596) EUR 30 m Initial Public Offering

Sword 2005 tombstone

Bryan, Garnier & Co, the European Growth Investment Bank, announces today the successful closing of a Eur 49 million secondary placement of 21 Centrale Partners’ 27.5% stake in SWORD (Euronext: SWP)

Stedim tombstone

Bryan, Garnier & Co, the European Growth investment bank successfully led the the secondary placement of a EUR 13M holding of 21 Investimenti in Stedim, a Euronext-listed company

Transgene 2005 tombstone

Bryan, Garnier & Co Leads a EUR 34,9 M follow-on offering of Ordinary Shares with Warrants (ABSA) from Leading International Institutional Investors for Transgene (Eurolist Paris : FR0005175080)

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }